Proton therapy breakthrough: fewer radiation sessions could boost lung cancer survival
NCT ID NCT01770418
First seen Jun 24, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This study tests a new way to deliver proton radiation for stage II-III non-small cell lung cancer. Instead of standard daily doses over many weeks, patients receive higher doses per session (hypofractionation) over a shorter time, combined with chemotherapy. The goal is to find the safest highest dose and see if it helps patients live at least 12 months. About 32 people are taking part.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Proton radiotherapy with chemotherapy (paclitaxel/carboplatin or cisplatin/etoposide)
What this could lead to
If successful, this could lead to a shorter, more effective radiation schedule for lung cancer, potentially improving survival and reducing side effects.
What could go wrong
This is an early-phase trial with only 32 participants, so results may not apply to all patients. Higher radiation doses also carry increased risk of lung or heart damage.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUNG NEOPLASMS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hampton University Proton Therapy Institute
Hampton, Virginia, 23666, United States
-
Maryland Proton Treatment Center
Baltimore, Maryland, 21201, United States
-
Northwestern Medicine Chicago Proton Center
Warrenville, Illinois, 60555, United States
-
Oklahoma Proton Center
Oklahoma City, Oklahoma, 73142, United States
-
Princeton ProCure Management LLC
Somerset, New Jersey, 08873, United States
-
University of Florida Proton Therapy Institute
Jacksonville, Florida, 32206, United States